AKEBIA THERAPEUTICS, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $74.0M | $149.8M |
| FY2022 | $34.1M | $5.2M | $90.5M |
| FY2023 | $17.2M | $-30.6M | $42.9M |
| FY2024 | $38.7M | $-49.2M | $51.9M |
| FY2025 | $48.3M | $32.6M | $184.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $0 | $74.0M | $149.8M |
| FY2022 | $34.1M | $5.2M | $90.5M |
| FY2023 | $17.2M | $-30.6M | $42.9M |
| FY2024 | $38.7M | $-49.2M | $51.9M |
| FY2025 | $48.3M | $32.6M | $184.8M |